|
|
||||
|
FDA plans praised, criticized
Email: Paula Park - paulapark52@hotmail.com News from The Scientist 2004, 5(1):20040819-03
|
||||
|
|
||||
|
The Food and Drug Administration's (FDA) proposal to reform the drug development process have been met with criticism from the Association of American Medical Colleges (AAMC), but with praise from other groups, including the Pharmaceutical Research and Manufacturers Association (PhRMA).
|
|
|||||||||
|
|||||||||
|